REFERENCES
- Balan G., Timmins P., Greene D. S., Marathe P. H. In vitro-in vivo correlation (IVIVC) models for metformin after administration of modified-release (MR) oral dosage forms to healthy human volunteers. J. Pharm. Sci., 2001; 8: 1176–1185
- Banker G. S., Ander L. R. Tablets. The theory and practice of industrial pharmacy, L. Lachman, H. A. Liberman, J. L. Kanig. Varghese Publishing House, Mumbai 1987; 293–345
- Bonderoni M. C., Caramella C., Sangalli M. E., Conte U., Hernadez R. M., Pedraz J. L. Reological behaviour of hydrophilic polymers and drug release from erodible matrices. J. Control. Release, 1992; 18: 205–212
- Chien Y. W. Novel drug delivery systems. Marcel Dekker, New York 1992
- Defang O., Shufang N., Wei L. In vitro and in vivo evaluation of two extended Release preparations of combination metformin and glipizide. Drug Dev. Ind. Pharm. 2005; 31: 677–685
- Dunn C. J., Peters D. H. Metformin: A review of its pharmacological properties and therapeutic use in non-insulin-dependent diabetes mellitus. Drugs, 1995; 49: 721–749
- Fassihi R. A., Ritschel W. A. Multiple layer, direct-compression controlled-release system: In vitro and in vivo evaluation. J. Pharm Sci. 1993; 82: 750–754
- Ford J. L., Rubinstein M. H., Hogan J. E. Formulation of sustained-release promethazine hydrochloride tablets using HPMC matrices. Int. J. Pharm., 1985; 24: 327–338
- Franz R. M., Systma J. A., Smith B. P., Lucisano L. J. In vitro evaluation of a mixed polymeric sustained release matrix using response surface methodology. J. Contr. Release 1987; 5: 159–172
- Higuchi W. I. Analysis of data on the medicament release from ointments. J. Pharm. Sci., 1962; 51: 802–804
- Hogan J. E. Hydroxypropyl methylcellulose sustained release technology. Drug Dev. Ind. Pharm., 1989; 15: 975–999
- Hsieh S. H., Lin J. D., Cheng H. Y., Ho C., Liou M. J. Sustained-release versus immediate-release glipizide for treatment of type 2 diabetes mellitus in Chinese patients: A randomized, double-blind, double-dummy, parallel-group, 12-week clinical study. Clin. Ther., 2006; 28: 1318–1326
- Korsmeyer R. W., Gurny R., Doelker E. M., Buri P., Peppas N. A. Mechanism of solute release from porous hydrophilic polymers. Int. J. Pharm. 1983; 15: 25–35
- Levina M., Rajabi-Siahboomi A. R. The influence of excipients on drug release from hydroxypropyl methylcellulose matrices. J. Pharm. Sci., 2004; 93: 2746–2754
- Lim C. J., Shell J. N. Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs. U.S. Patent 6682759., 2004
- Medical Economics Co. Physicians’ desk reference53rd. Author, Montvale, NJ 1999
- Mutalik S., Hiremath D. Formulation and evaluation of chitosan matrix tablets of nifedipine. The Eastern Pharmacist 2000; 2: 109–111
- Peppas N. A. Analysis of Fickian and non-Fickian drug release from polymers. Pharm. Acta Helv., 1985; 60: 110–111
- Ravi Kumar M. N. V., Kumar N. Polymeric controlled drug-delivery systems: Perspective issues and opportunities. Drug Dev. Ind. Pharm. 2001; 27: 1–30
- Rawlins E. A. Bentley's text book of pharmaceutics. Cassell and Collier Macmillan, LondonEngland 1977
- Scheen A. J. Clinical pharmacokinetics of metformin. Clin. Pharmacokinet. 1996; 30: 359–371
- Siconolfi-Baez L., Banerje M. A., Lebovitz H. E. Characterization and significance of sulfonylurea receptors. Diabetes Care, 1990; 13: 2–8
- Stith B. J., Goalstone M. L., Espinoza R., Mossel C., Roberts D., Wiernsperger N. The antidiabetic drug metformin elevates receptor tyrosine kinase activity and inositol 1, 4, 5-triphosphate mass in Xenopus oocytes. Endocrinology 1996; 137: 2990–2999
- Tripathi K. D. Essentials of medical pharmacology. Jaypee Brothers Medical Publishers Pvt. Ltd, New DelhiIndia 2004; 235–253
- United States Pharmacopeia. United States pharmacopeia–national formulary. United States Pharmacopeial Convention, Rockville 2000, (USP 24/NF 19)